Useful takeaways from this story.

Late breaking results (a) Efficacy and Safety of Remibrutinib vs Teriflunomide in Relapsing Multiple Sclerosis:

Prediction…this shows significant benefit to tolebrutinib and evobrutinib.

What's the difference?…The teriflunomide group…we will see.

Building the complete brief

The page is ready to read now. The fuller skim-friendly version will appear here automatically.

The useful part

Late breaking results (a) Efficacy and Safety of Remibrutinib vs Teriflunomide in Relapsing Multiple Sclerosis: Prediction…this shows significant benefit to tolebrutinib and evobrutinib. What's the difference?…The teriflunomide group…we will see.

How it works

  • Prediction…this shows significant benefit to tolebrutinib and evobrutinib.

Details worth keeping

What's the difference?…The teriflunomide group…we will see.

Keep reading in the app

Open the app view to save this story, compare related coverage, and continue from the same source.

Open in app